Your Article Summary
See Latest ArticlesClinicopathological analysis of paraganglioma with literature review
World Journal of Gastroenterology, 06/29/09
Feng N et al. - Vimentin may be useful in the differential diagnosis between malignant and benign tumors. The difference in the expression of this marker in the tumors could be a clue to the future clinical diagnosis. The malignancy, metastasis and the nodal status may predict the prognosis of this disease.
Related Articles
Parasympathetic Paragangliomas Are Part of the Von Hippel-Lindau Syndrome
Journal of Clinical Endocrinology and Metabolism, 10/14/09
Relevance Score: 88%
Composite paraganglioma-ganglioneuroma in the retroperitoneum
World Journal of Surgical Oncology, 11/09/09
Relevance Score: 84%
Carney Triad in an Adult with Aggressive Behavior: The First Case in Korea
Yonsei Medical Journal, 10/30/09
Relevance Score: 84%
Endoglin as a marker in cervical paragangliomas
Head & Neck, 10/15/09
Relevance Score: 83%
Paragangliomas of head and neck: a treatment option with CyberKnife radiosurgery
Neurological Sciences, 10/08/09
Relevance Score: 83%
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Delay in Diagnostic Workup and Treatment of Esophageal Cancer
Journal of Gastrointestinal Surgery, 12/17/09
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
Alimentary Pharmacology and Therapeutics, 12/17/09